GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Tobacco Products » Philip Morris International Inc (FRA:4I1) » Definitions » Change In Payables And Accrued Expense

Philip Morris International (FRA:4I1) Change In Payables And Accrued Expense : €-272 Mil (TTM As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Philip Morris International Change In Payables And Accrued Expense?

Philip Morris International's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was €307 Mil. It means Philip Morris International's Accounts Payable & Accrued Expense increased by €307 Mil from Sep. 2023 to Dec. 2023 .

Philip Morris International's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was €-264 Mil. It means Philip Morris International's Accounts Payable & Accrued Expense declined by €264 Mil from Dec. 2022 to Dec. 2023 .


Philip Morris International Change In Payables And Accrued Expense Historical Data

The historical data trend for Philip Morris International's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philip Morris International Change In Payables And Accrued Expense Chart

Philip Morris International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Payables And Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 405.90 333.73 577.91 678.74 -264.10

Philip Morris International Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -135.43 -248.29 -195.83 307.20 -

Philip Morris International Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-272 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Philip Morris International Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Philip Morris International's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Philip Morris International (FRA:4I1) Business Description

Address
677 Washington Boulevard, Suite 1100, Stamford, Connecticut, New York, NY, USA, 06901
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from cigarettes with the 2022 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches, primarily in the U.S. and Scandinavia. It diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.

Philip Morris International (FRA:4I1) Headlines

No Headlines